{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:52:54Z","timestamp":1787770374394,"version":"build-2784847793"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502133"],"award-info":[{"award-number":["81502133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7172205"],"award-info":[{"award-number":["7172205"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.phrs.2021.105869","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T01:37:40Z","timestamp":1630633060000},"page":"105869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients"],"prefix":"10.1016","volume":"173","author":[{"given":"Ji-Hai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.phrs.2021.105869_bib1","doi-asserted-by":"crossref","first-page":"12974","DOI":"10.1111\/cpr.12974","article-title":"STAT3 and its targeting inhibitors in osteosarcoma","volume":"54","author":"Liu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.phrs.2021.105869_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-021-00519-8","article-title":"Advancing therapy for osteosarcoma","author":"Gill","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2021.105869_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.594445","article-title":"Anti-angiogenic agents in management of sarcoma patients: overview of published trials","volume":"10","author":"Cren","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2021.105869_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.586580","article-title":"Macrophages in osteosarcoma immune microenvironment: implications for immunotherapy","volume":"10","author":"Luo","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2021.105869_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.667109","article-title":"Osteosarcoma-derived small extracellular vesicles enhance tumor metastasis and suppress osteoclastogenesis by miR-146a-5p","volume":"11","author":"Araki","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2021.105869_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.643522","article-title":"LRH1 acts as an oncogenic driver in human osteosarcoma and pan-cancer","volume":"9","author":"Song","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105869_bib7","doi-asserted-by":"crossref","first-page":"19138","DOI":"10.1038\/s41598-020-75995-6","article-title":"Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis","volume":"10","author":"Ingvarsen","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2021.105869_bib8","article-title":"Light-responsive micelles loaded with doxorubicin for osteosarcoma suppression","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105869_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105684","article-title":"Advances in targeted therapy for osteosarcoma based on molecular classification","volume":"169","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.phrs.2021.105869_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1002\/ijc.32180","article-title":"Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma","volume":"145","author":"Wang","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2021.105869_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-030-43085-6_4","article-title":"Targeting the cancer epigenome with histone deacetylase inhibitors in osteosarcoma","volume":"1258","author":"Collier","year":"2020","journal-title":"Adv. Exp. Med Biol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105869_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11864-020-00760-w","article-title":"Role of TKI for metastatic osteogenic sarcoma","volume":"21","author":"Duffaud","year":"2020","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.phrs.2021.105869_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105463","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2021 update","volume":"165","author":"Roskoski","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105869_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104609","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2020 update","volume":"152","author":"Roskoski","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105869_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2019.03.006","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors","volume":"144","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105869_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102221","article-title":"Cabozantinib: an evolving therapy for hepatocellular carcinoma","volume":"98","author":"El-Khoueiry","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phrs.2021.105869_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/JHC.S300182","article-title":"Hepatocellular carcinoma: an overview of the changing landscape of treatment options","volume":"8","author":"Koulouris","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.phrs.2021.105869_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/JHC.S268310","article-title":"The role of cabozantinib as a therapeutic option for hepatocellular carcinoma: current landscape and future challenges","volume":"8","author":"D\u2019Alessio","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"12","key":"10.1016\/j.phrs.2021.105869_bib19","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1158\/1535-7163.MCT-18-1399","article-title":"Cabozantinib in combination with immunotherapy for advanced renal cell carcinoma and urothelial carcinoma: rationale and clinical evidence","volume":"18","author":"Paulo","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"11","key":"10.1016\/j.phrs.2021.105869_bib20","doi-asserted-by":"crossref","first-page":"9686","DOI":"10.1039\/D0FO01542C","article-title":"EGCG targeting Notch to attenuate renal fibrosis via inhibition of TGFbeta\/Smad3 signaling pathway activation in streptozotocin-induced diabetic mice","volume":"11","author":"Zhu","year":"2020","journal-title":"Food Funct."},{"issue":"3","key":"10.1016\/j.phrs.2021.105869_bib21","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1039\/C9FO02879J","article-title":"Natural cordycepin induces apoptosis and suppresses metastasis in breast cancer cells by inhibiting the Hedgehog pathway","volume":"11","author":"Liu","year":"2020","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.phrs.2021.105869_bib22","doi-asserted-by":"crossref","first-page":"14809","DOI":"10.1038\/s41598-017-14897-6","article-title":"Progressive and prognosis value of Notch receptors and ligands in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2021.105869_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.119007","article-title":"\u03b3-Secretase inhibitors for breast cancer and hepatocellular carcinoma: from mechanism to treatment","volume":"268","author":"Jia","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2021.105869_bib24","article-title":"miR-27-3p enhances the sensitivity of triple-negative breast cancer cells to the antitumor agent olaparib by targeting PSEN-1, the catalytic subunit of \u0393-secretase","volume":"11","author":"Zhao","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2021.105869_bib25","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.1039\/D1FO01275D","article-title":"A systematic study on the chemical diversity and efficacy of the inflorescence and succulent stem of Cynomorium songaricum","volume":"12","author":"Zheng","year":"2021","journal-title":"Food Funct."},{"issue":"9","key":"10.1016\/j.phrs.2021.105869_bib26","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41419-020-02940-w","article-title":"P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma","volume":"11","author":"Costa","year":"2020","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.phrs.2021.105869_bib27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41419-020-02840-z","article-title":"LncRNA SNAI3-AS1 promotes PEG10-mediated proliferation and metastasis via decoying of miR-27a-3p and miR-34a-5p in hepatocellular carcinoma","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.phrs.2021.105869_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41419-020-02778-2","article-title":"Immune checkpoint inhibitor induces cardiac injury through polarizing macrophages via modulating microRNA-34a\/Kruppel-like factor 4 signaling","volume":"11","author":"Xia","year":"2020","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.phrs.2021.105869_bib29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbagen.2016.04.007","article-title":"Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents","volume":"1860","author":"Jia","year":"2016","journal-title":"Biochim Biophys. Acta"},{"key":"10.1016\/j.phrs.2021.105869_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105071","article-title":"DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents","volume":"160","author":"Ma","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105869_bib31","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.2147\/CMAR.S268380","article-title":"CASC8 lncRNA promotes the proliferation of retinoblastoma cells through downregulating miR34a methylation","volume":"12","author":"Yang","year":"2020","journal-title":"Cancer Manag Res."},{"key":"10.1016\/j.phrs.2021.105869_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144963","article-title":"Comparative analysis of epi-miRNA expression levels in local\/locally advanced and metastatic prostate cancer patients","volume":"758","author":"Gurbuz","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.phrs.2021.105869_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer","author":"Nishiyama","year":"2021","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.phrs.2021.105869_bib34","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13148-021-01111-8","article-title":"Epigenetic mechanisms underlying prostate cancer radioresistance","volume":"13","author":"Macedo-Silva","year":"2021","journal-title":"Clin. Epigenetics"},{"issue":"1","key":"10.1016\/j.phrs.2021.105869_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41576-020-00287-8","article-title":"Active turnover of DNA methylation during cell fate decisions","volume":"22","author":"Parry","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"10","key":"10.1016\/j.phrs.2021.105869_bib36","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41419-020-03098-1","article-title":"Downregulation of PUMA underlies resistance to FGFR1 inhibitors in the stem cell leukemia\/lymphoma syndrome","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2021.105869_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174222","article-title":"Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents","volume":"907","author":"Zou","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2021.105869_bib38","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.2147\/OTT.S244474","article-title":"Novel mTOR inhibitor enhances the sensitivity of hepatocellular carcinoma cells to molecular targeting agents","volume":"13","author":"Feng","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"9","key":"10.1016\/j.phrs.2021.105869_bib39","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41419-020-02934-8","article-title":"Combined inhibition of JAK1\/2 and DNMT-1 by newly identified small-molecule compounds synergistically suppresses the survival and proliferation of cervical cancer cells","volume":"11","author":"She","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.phrs.2021.105869_bib40","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.apsb.2019.04.001","article-title":"Direct interaction of DNMT inhibitors to PrPC suppresses pathogenic process of prion","volume":"9","author":"Kim","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.phrs.2021.105869_bib41","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1158\/0008-5472.CAN-08-3669","article-title":"A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation","volume":"69","author":"Datta","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2021.105869_bib42","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.2147\/OTT.S215145","article-title":"miR-596 suppresses the expression of Survivin and enhances the sensitivity of osteosarcoma cells to the molecular targeting agent anlotinib","volume":"12","author":"Wang","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"4","key":"10.1016\/j.phrs.2021.105869_bib43","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbagen.2018.01.011","article-title":"Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma","volume":"1862","author":"Feng","year":"2018","journal-title":"Biochim Biophys. Acta Gen. Subj."},{"issue":"9","key":"10.1016\/j.phrs.2021.105869_bib44","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41419-019-1884-7","article-title":"SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity","volume":"10","author":"Yin","year":"2019","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.phrs.2021.105869_bib45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/s41419-020-03053-0","article-title":"FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c\/PXR axis","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2021.105869_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119521","article-title":"Novel small molecular inhibitor of Pit-Oct-Unc transcription factor 1 suppresses hepatocellular carcinoma cell proliferation","volume":"277","author":"Wang","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2021.105869_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174214","article-title":"Novel small molecule inhibitors of the transcription factor ETS-1 and their antitumor activity against hepatocellular carcinoma","volume":"906","author":"Jie","year":"2021","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.phrs.2021.105869_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105648","article-title":"Phthalates promote the invasion of hepatocellular carcinoma cells by enhancing the interaction between Pregnane X receptor and E26 transformation specific sequence 1","volume":"169","author":"Du","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.phrs.2021.105869_bib49","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1039\/D0FO02270E","article-title":"Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR-148a\/PXR axis","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"issue":"2","key":"10.1016\/j.phrs.2021.105869_bib50","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"15","key":"10.1016\/j.phrs.2021.105869_bib51","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1016\/j.jmb.2015.06.001","article-title":"Crystal structure of human DNA methyltransferase 1","volume":"427","author":"Zhang","year":"2015","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.phrs.2021.105869_bib52","article-title":"MDM2 binding protein induces the resistance of hepatocellular carcinoma cells to molecular targeting agents via enhancing the transcription factor activity of the pregnane X receptor","volume":"11","author":"Jiang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2021.105869_bib53","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.phrs.2018.08.003","article-title":"ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR","volume":"135","author":"Shao","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.phrs.2021.105869_bib54","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41419-019-2023-1","article-title":"MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents","volume":"10","author":"Bin","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2021.105869_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.phrs.2019.03.009","article-title":"Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo","volume":"143","author":"Wei","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.phrs.2021.105869_bib56","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ame2.12085","article-title":"Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient-derived cell invasion via a novel in vivo tumor model","volume":"2","author":"Sun","year":"2019","journal-title":"Anim. Model Exp. Med."},{"issue":"3","key":"10.1016\/j.phrs.2021.105869_bib57","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ame2.12076","article-title":"The multiple-kinase inhibitor lenvatinib inhibits the proliferation of acute myeloid leukemia cells","volume":"2","author":"Feng","year":"2019","journal-title":"Anim. Model Exp. Med."},{"key":"10.1016\/j.phrs.2021.105869_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114057","article-title":"Cimicifuga dahurica extract inhibits the proliferation, migration and invasion of breast cancer cells MDA-MB-231 and MCF-7 in vitro and in vivo","volume":"277","author":"Jia","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2021.105869_bib59","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.2147\/CMAR.S200540","article-title":"MicroRNA-3662 targets ZEB1 and attenuates the invasion of the highly aggressive melanoma cell line A375","volume":"11","author":"Lin","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.phrs.2021.105869_bib60","article-title":"Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib","volume":"161","author":"Chunzhan","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105869_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105392","article-title":"Anlotinib enhances the antitumor activity of radiofrequency ablation on lung squamous cell carcinoma","volume":"164","author":"Zhou","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105869_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-3-030-43085-6_8","article-title":"Wnt signaling in osteosarcoma","volume":"1258","author":"Singla","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.phrs.2021.105869_bib63","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-3-030-43085-6_4","article-title":"Targeting the cancer epigenome with histone deacetylase inhibitors in osteosarcoma","volume":"1258","author":"Collier","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2021.105869_bib64","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1039\/C9FO01901D","article-title":"Curcumin-enhanced antitumor effects of sorafenib via regulating the metabolism and tumor microenvironment","volume":"11","author":"Man","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2021.105869_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105195","article-title":"PI3K\/AKT\/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma","volume":"160","author":"Wu","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.phrs.2021.105869_bib66","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/cddis.2014.440","article-title":"Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib","volume":"5","author":"Liu","year":"2014","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.phrs.2021.105869_bib67","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-020-2558-1","article-title":"Differential effectiveness of tyrosine kinase inhibitors in 2D\/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells","volume":"11","author":"Rodr\u00edguez-Hern\u00e1ndez","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2021.105869_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110036","article-title":"PDGF-PDGFR network differentially regulates the fate, migration, proliferation, and cell cycle progression of myogenic cells","volume":"84","author":"Contreras","year":"2021","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2021.105869_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109803","article-title":"Imatinib exhibit synergistic pleiotropy in the prevention of colorectal cancer by suppressing proinflammatory, cell survival and angiogenic signaling","volume":"76","author":"Dhiman","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2021.105869_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109789","article-title":"Signaling pathways affected by mutations causing osteogenesis imperfecta","volume":"76","author":"Etich","year":"2020","journal-title":"Cell. Signal."},{"key":"10.1016\/j.phrs.2021.105869_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105732","article-title":"New frontiers against sorafenib resistance in renal cell carcinoma: from molecular mechanisms to predictive biomarkers","volume":"170","author":"He","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.phrs.2021.105869_bib72","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/aps.2017.5","article-title":"New knowledge of the mechanisms of sorafenib resistance in liver cancer","volume":"38","author":"Yan-Jing","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"38","key":"10.1016\/j.phrs.2021.105869_bib73","doi-asserted-by":"crossref","first-page":"27343","DOI":"10.1074\/jbc.M113.490482","article-title":"Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines","volume":"288","author":"Kang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2021.105869_bib74","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/vetsci7040146","article-title":"MicroRNAs as biomarkers in canine osteosarcoma: a new future?","volume":"7","author":"Gourbault","year":"2020","journal-title":"Vet. Sci."},{"issue":"8","key":"10.1016\/j.phrs.2021.105869_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153038","article-title":"MicroRNA expression in relation with clinical evolution of osteosarcoma","volume":"216","author":"Monterde-Cruz","year":"2020","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.phrs.2021.105869_bib76","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13018-021-02372-y","article-title":"The role of Notch ligand Jagged1 in osteosarcoma proliferation, metastasis, and recurrence","volume":"16","author":"Zhang","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"key":"10.1016\/j.phrs.2021.105869_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174058","article-title":"Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma","volume":"899","author":"Dai","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2021.105869_bib78","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.bbagen.2016.04.007","article-title":"Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents","volume":"1860","author":"Jia","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2021.105869_bib79","article-title":"Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo","volume":"148","author":"Hong-Yuan","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105869_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117343","article-title":"Novel ADAM-17 inhibitor ZLDI-8 inhibits the metastasis of hepatocellular carcinoma by reversing epithelial-mesenchymal transition in vitro and in vivo","volume":"244","author":"Lu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2021.105869_bib81","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2017.07.021","article-title":"Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversal","volume":"124","author":"An","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2021.105869_bib82","article-title":"Down-regulation of CIDEA promoted tumor growth and contributed to cisplatin resistance by regulating the JNK-p21\/bad signaling pathways in esophageal squamous cell carcinoma","volume":"10","author":"Gao","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2021.105869_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.591937","article-title":"Integrative analysis of multi-omics identified the prognostic biomarkers in acute myelogenous leukemia","volume":"10","author":"Zheng","year":"2020","journal-title":"Front. Oncol."},{"issue":"7846","key":"10.1016\/j.phrs.2021.105869_bib84","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-020-03069-8","article-title":"Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases","volume":"590","author":"Li","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2021.105869_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.573515","article-title":"SETDB1 overexpression sets an intertumoral transcriptomic divergence in non-small cell lung carcinoma","volume":"11","author":"Kang","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.phrs.2021.105869_bib86","article-title":"Selective estrogen receptor modulator-like activities of herba epimedii extract and its interactions with tamoxifen and raloxifene in bone cells and tissues","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105869_bib87","doi-asserted-by":"crossref","first-page":"13171","DOI":"10.2147\/OTT.S266435","article-title":"The lncRNA LINC00691 functions as a ceRNA for miRNA-1256 to suppress osteosarcoma by regulating the expression of ST5","volume":"13","author":"Wan","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.phrs.2021.105869_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111155","article-title":"Cardamonin inhibits the growth of human osteosarcoma cells through activating P38 and JNK signaling pathway","volume":"134","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2021.105869_bib89","article-title":"Emerging roles and potential biological value of CircRNA in osteosarcoma","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"issue":"21","key":"10.1016\/j.phrs.2021.105869_bib90","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S1470-2045(21)00422-8","article-title":"Antiangiogenic agents combined with systemic chemotherapy in refractory osteosarcoma","volume":"22","author":"Rutkowski","year":"2021","journal-title":"Lancet Oncol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821004539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821004539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T20:48:31Z","timestamp":1734382111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821004539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":90,"alternative-id":["S1043661821004539"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105869","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105869"}}